These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37784253)

  • 21. Chordoma: Immunohistochemical Analysis of Brachury.
    Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
    Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intradural chordoma presenting with intratumoral bleeding.
    Vellutini Ede A; de Oliveira MF
    J Clin Neurosci; 2016 Mar; 25():139-42. PubMed ID: 26563604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
    Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chordoma].
    George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
    Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence.
    Deniz ML; Kiliç T; Almaata I; Kurtkaya O; Sav A; Pamir MN
    Neurosurgery; 2002 Sep; 51(3):753-60; discussion 760. PubMed ID: 12188955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor (EGFR) status in chordoma.
    Ptaszyński K; Szumera-Ciećkiewicz A; Owczarek J; Mrozkowiak A; Pekul M; Barańska J; Rutkowski P
    Pol J Pathol; 2009; 60(2):81-7. PubMed ID: 19886182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of H3K27 trimethylation in a distinct group of de-differentiated chordoma of the skull base.
    Makise N; Shimoi T; Sunami K; Aoyagi Y; Kobayashi H; Tanaka S; Kawai A; Yonemori K; Ushiku T; Yoshida A
    Histopathology; 2023 Feb; 82(3):420-430. PubMed ID: 36217885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular features and vulnerabilities of recurrent chordomas.
    Seeling C; Lechel A; Svinarenko M; Möller P; Barth TFE; Mellert K
    J Exp Clin Cancer Res; 2021 Jul; 40(1):244. PubMed ID: 34330313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal profiling of chordoma immunity reveals distinct immune contextures.
    van Oost S; Meijer DM; Ijsselsteijn ME; Roelands JP; van den Akker BEMW; van der Breggen R; Briaire-de Bruijn IH; van der Ploeg M; Wijers-Koster PM; Polak SB; Peul WC; van der Wal RJP; de Miranda NFCC; Bovee JVMG
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical Management of Skull Base and Spine Chordomas.
    Passer JZ; Alvarez-Breckenridge C; Rhines L; DeMonte F; Tatsui C; Raza SM
    Curr Treat Options Oncol; 2021 Mar; 22(5):40. PubMed ID: 33743089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteogenomic characterization of skull-base chordoma.
    Zhang Q; Xu Z; Han R; Wang Y; Ye Z; Zhu J; Cai Y; Zhang F; Zhao J; Yao B; Qin Z; Qiao N; Huang R; Feng J; Wang Y; Rui W; He F; Zhao Y; Ding C
    Nat Commun; 2024 Sep; 15(1):8338. PubMed ID: 39333076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of a Category Based on Electron Microscopic Features of Clival Chordomas.
    Bai J; Zhai Y; Wang S; Gao H; Du J; Wang J; Li M; Li C; Gui S; Zhang C; Sun Y; Zhang Y
    World Neurosurg; 2017 Mar; 99():282-287. PubMed ID: 27916725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
    Scheil S; Brüderlein S; Liehr T; Starke H; Herms J; Schulte M; Möller P
    Genes Chromosomes Cancer; 2001 Nov; 32(3):203-11. PubMed ID: 11579460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological implications of TIM3
    Zhou J; Jiang Y; Zhang H; Chen L; Luo P; Li L; Zhao J; Lv F; Zou D; Zhang Y; Jing Z
    Cancer Immunol Immunother; 2019 Jul; 68(7):1157-1169. PubMed ID: 31197461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas.
    Orzan F; Terreni MR; Longoni M; Boari N; Mortini P; Doglioni C; Riva P
    Oncol Rep; 2007 Jul; 18(1):249-52. PubMed ID: 17549375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skull base and nonskull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability.
    Naka T; Boltze C; Samii A; Herold C; Ostertag H; Iwamoto Y; Oda Y; Tsuneyoshi M; Kuester D; Roessner A
    Cancer; 2003 Nov; 98(9):1934-41. PubMed ID: 14584077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.
    Parry DM; McMaster ML; Liebsch NJ; Patronas NJ; Quezado MM; Zametkin D; Yang XR; Goldstein AM
    J Neurosurg; 2021 May; 134(5):1399-1408. PubMed ID: 32559743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First cytogenetic study of a recurrent familial chordoma of the clivus.
    Dalprà L; Malgara R; Miozzo M; Riva P; Volonte M; Larizza L; Fuhrman Conti AM
    Int J Cancer; 1999 Mar; 81(1):24-30. PubMed ID: 10077147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
    Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
    Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.